Context
Context. Explaining the issues

Context

Audio: 
Shared via
WPR
A Marinette manufacturer of firefighting foam will provide bottled water for homeowners after their private wells were found to have elevated levels of so-called forever chemicals known as PFAS.
Audio: 
Shared via
WPR
Preliminary numbers from the April 7 election show voters approved school district funding requests in near-record numbers.
Audio: 
Shared via
WPR
The state Assembly has approved, in its first-ever virtual session, a bill to address problems created by the COVID-19 pandemic in Wisconsin.
Shared via
PBS Wisconsin
Baraboo-based Hack Away Forest Products has had to lay off the majority of its full-time employees, as the market for its wood has come crashing down.
Shared via
PBS Wisconsin
Every business in America is being significantly affected by the COVID-19 outbreak and related economic woes. For non-profits, the impact may be no less significant. One online CNN commentator recently warned it could be an “extinction-level event” for many community service organizations.
Shared via
WPR
President Trump has riled officials from states across the country by saying that the federal government has the authority to reopen the country. Legal experts agree that the power to lift state stay-at-home orders belongs to state officials.
Shared via
WPR
The state Department of Health Services announced on April 14 that there are 3,555 positive cases of COVID-19 in Wisconsin, a jump of 127 cases from the day before.
Audio: 
Shared via
WPR
Gov. Tony Evers’ safer-at-home order allows travel related to the exchange of children pursuant to custody orders, but many people still have questions. Some parents worry about the health and safety of their kids while others fear their kids may be kept away from them.
Audio: 
Shared via
WPR
Rural Wisconsin is vulnerable to COVID-19, and emergency medical services are turning to creative solutions to find protective gear to keep their responders virus-free.
Audio: 
Shared via
WPR
The results aren't known yet, but an experimental treatment giving severely ill patients antibodies from those who have recovered from COVID-19 has begun at hospitals in Milwaukee and Madison.